SAB Biotherapeutics, Inc. (SABS)

NASDAQ: SABS · Real-Time Price · USD

3.800

+0.120 (3.26%)

At close: May 6, 2026, 4:00 PM EDT

4.040

+0.240 (6.32%)

Pre-market: May 7, 2026, 6:37 AM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Biotechnology		1.32M	2.24M	23.90M	60.88M	55.24M
Biotechnology Growth		-40.94%	-90.63%	-60.73%	10.21%	1504.91%
Total		1.32M	2.24M	23.90M	60.88M	55.24M
Total Growth		-40.94%	-90.63%	-60.73%	10.21%	1504.91%

Source: S&P Global Market Intelligence.